IL145635A0 - Taxane formulations having improved solubility - Google Patents
Taxane formulations having improved solubilityInfo
- Publication number
- IL145635A0 IL145635A0 IL14563501A IL14563501A IL145635A0 IL 145635 A0 IL145635 A0 IL 145635A0 IL 14563501 A IL14563501 A IL 14563501A IL 14563501 A IL14563501 A IL 14563501A IL 145635 A0 IL145635 A0 IL 145635A0
- Authority
- IL
- Israel
- Prior art keywords
- improved solubility
- taxane formulations
- taxane
- formulations
- solubility
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17979300P | 2000-02-02 | 2000-02-02 | |
| US17967400P | 2000-02-02 | 2000-02-02 | |
| US17966900P | 2000-02-02 | 2000-02-02 | |
| US17967200P | 2000-02-02 | 2000-02-02 | |
| US17967000P | 2000-02-02 | 2000-02-02 | |
| US17968400P | 2000-02-02 | 2000-02-02 | |
| US17978200P | 2000-02-02 | 2000-02-02 | |
| US17967100P | 2000-02-02 | 2000-02-02 | |
| PCT/US2001/003624 WO2001057013A1 (en) | 2000-02-02 | 2001-02-02 | Taxane formulations having improved solubility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL145635A0 true IL145635A0 (en) | 2002-06-30 |
Family
ID=27575082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14563501A IL145635A0 (en) | 2000-02-02 | 2001-02-02 | Taxane formulations having improved solubility |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1175414A1 (en) |
| KR (1) | KR20010111580A (en) |
| AU (1) | AU3481001A (en) |
| BR (1) | BR0104358A (en) |
| HU (1) | HUP0200995A3 (en) |
| IL (1) | IL145635A0 (en) |
| NO (1) | NO20014752L (en) |
| NZ (1) | NZ514073A (en) |
| WO (1) | WO2001057013A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO5280224A1 (en) | 2000-02-02 | 2003-05-30 | Univ Florida State Res Found | SUBSTITUTED TAXANS WITH ESTER IN C7, USEFUL AS ANTITUMOR AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| IL145640A (en) | 2000-02-02 | 2007-02-11 | Univ Florida State Res Found | C10 carbamoyloxy substituted taxanes as antitumor agents |
| JP2003521514A (en) | 2000-02-02 | 2003-07-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | C10 heterosubstituted acetate taxanes as antitumor agents |
| RU2265019C2 (en) | 2000-02-02 | 2005-11-27 | Флорида Стейт Юниверсити Рисерч Фаундейшн, Инк. | Taxanes, pharmaceutical compositions, inhibition method |
| WO2001057029A1 (en) | 2000-02-02 | 2001-08-09 | Florida State University Research Foundation, Inc. | C7 heterosubstituted acetate taxanes as antitumor agents |
| US6649632B2 (en) | 2000-02-02 | 2003-11-18 | Fsu Research Foundation, Inc. | C10 ester substituted taxanes |
| JP2003522171A (en) | 2000-02-02 | 2003-07-22 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | C10 carbonate substituted taxanes as antitumor agents |
| CA2354478A1 (en) * | 2001-07-31 | 2003-01-31 | Florida State University Research Foundation, Inc. | C10 carbonate substituted taxanes |
| CA2354486A1 (en) * | 2001-07-31 | 2003-01-31 | Florida State University Research Foundation, Inc. | C7 ester substituted taxanes |
| KR20050032110A (en) * | 2002-08-02 | 2005-04-06 | 이뮤노젠 아이엔씨 | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| US7390898B2 (en) | 2002-08-02 | 2008-06-24 | Immunogen Inc. | Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| SV2006002010A (en) | 2004-02-13 | 2006-08-23 | Univ Florida State Res Found | REPLACED TAXANS WITH CYCLOPENTILO ESTERS IN C10 |
| JP2007527432A (en) | 2004-03-05 | 2007-09-27 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | C7 lactyloxy-substituted taxane |
| US8242166B2 (en) | 2008-03-31 | 2012-08-14 | Florida State University Research Foundation, Inc. | C(10) ethyl ester and C(10) cyclopropyl ester substituted taxanes |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5243045A (en) * | 1991-09-23 | 1993-09-07 | Florida State University | Certain alkoxy substituted taxanes and pharmaceutical compositions containing them |
| US5250683A (en) * | 1991-09-23 | 1993-10-05 | Florida State University | Certain substituted taxanes and pharmaceutical compositions containing them |
| MX9307777A (en) * | 1992-12-15 | 1994-07-29 | Upjohn Co | 7-HALO-Y 7ß, 8ß-METHANE-TAXOLES, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
| EP0727992A4 (en) * | 1993-10-20 | 2001-01-31 | Enzon Inc | 2'- and/or 7- substituted taxoids |
| US6100411A (en) * | 1994-10-28 | 2000-08-08 | The Research Foundation Of State University Of New York | Taxoid anti-tumor agents and pharmaceutical compositions thereof |
| WO1996013495A1 (en) * | 1994-10-28 | 1996-05-09 | The Research Foundation Of State University Of New York | Taxoid derivatives, their preparation and their use as antitumor agents |
| US5801191A (en) * | 1995-06-01 | 1998-09-01 | Biophysica Foundation | Taxoids |
| EP0930309A4 (en) * | 1996-07-15 | 2001-09-26 | Yakult Honsha Kk | Taxane derivatives and drugs containing the same |
| JPH1192468A (en) * | 1997-09-17 | 1999-04-06 | Yakult Honsha Co Ltd | New taxane derivative |
| WO1999032473A1 (en) * | 1997-12-19 | 1999-07-01 | Kabushiki Kaisha Yakult Honsha | Taxane derivatives |
| JP2003026673A (en) * | 1999-03-05 | 2003-01-29 | Asahi Kasei Corp | Osteoplasty accelerator |
-
2001
- 2001-02-02 BR BR0104358-7A patent/BR0104358A/en not_active IP Right Cessation
- 2001-02-02 HU HU0200995A patent/HUP0200995A3/en unknown
- 2001-02-02 NZ NZ514073A patent/NZ514073A/en not_active Application Discontinuation
- 2001-02-02 KR KR1020017012367A patent/KR20010111580A/en not_active Application Discontinuation
- 2001-02-02 AU AU34810/01A patent/AU3481001A/en not_active Abandoned
- 2001-02-02 IL IL14563501A patent/IL145635A0/en unknown
- 2001-02-02 WO PCT/US2001/003624 patent/WO2001057013A1/en not_active Application Discontinuation
- 2001-02-02 EP EP01906972A patent/EP1175414A1/en not_active Withdrawn
- 2001-10-01 NO NO20014752A patent/NO20014752L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3481001A (en) | 2001-08-14 |
| WO2001057013A1 (en) | 2001-08-09 |
| NO20014752D0 (en) | 2001-10-01 |
| HUP0200995A2 (en) | 2002-07-29 |
| HUP0200995A3 (en) | 2005-02-28 |
| BR0104358A (en) | 2002-01-02 |
| KR20010111580A (en) | 2001-12-19 |
| NZ514073A (en) | 2004-02-27 |
| EP1175414A1 (en) | 2002-01-30 |
| NO20014752L (en) | 2001-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301413A3 (en) | Vaccine compositions | |
| HUP0302117A3 (en) | Vaccine composition | |
| GB0001621D0 (en) | Pharmaceutical compositions | |
| GB0020089D0 (en) | Vaccine Composition | |
| AU6219601A (en) | Pharmaceutical compositions | |
| PL350075A1 (en) | Taxane formulations having improved solubility | |
| GB0009584D0 (en) | Pharmaceutical compositions | |
| GB0019232D0 (en) | Antiperspirant formulations | |
| EP1320385A4 (en) | Combination compositions | |
| AU8576801A (en) | Pharmaceutical compositions | |
| IL145635A0 (en) | Taxane formulations having improved solubility | |
| GB0015490D0 (en) | Novel formulations | |
| AU1390002A (en) | Pharmaceutical compositions | |
| GB0019651D0 (en) | Compositions | |
| GB0008485D0 (en) | Pharmaceutical compositions | |
| GB0019230D0 (en) | Antiperspirant formulations | |
| GB0009613D0 (en) | Pharmaceutical compositions | |
| GB0009607D0 (en) | Medical compositions | |
| HK1061978A1 (en) | Lipid peroxide-lowering compositions | |
| IL155690A0 (en) | Adjuvant combination formulations | |
| GB0004518D0 (en) | Compositions | |
| HK1047933A1 (en) | Taxane formulations having improved solubility | |
| AU8254101A (en) | Medicinal compositions | |
| GB0004522D0 (en) | Compositions | |
| GB0022027D0 (en) | Disfectant formulations |